![Heads UP - Episode 101: Trudhesa Nasal Spray for the Acute Treatment of Migraine | National Headache Foundation Heads UP - Episode 101: Trudhesa Nasal Spray for the Acute Treatment of Migraine | National Headache Foundation](https://headaches.org/wp-content/uploads/2021/09/impel-neuropharma-updated-768x499-1.png)
Heads UP - Episode 101: Trudhesa Nasal Spray for the Acute Treatment of Migraine | National Headache Foundation
![Trudhesa DHE Nasal Spray: Top 7 Reasons to Consider DHE for Migraine Treatment - Virtual Headache Specialist Trudhesa DHE Nasal Spray: Top 7 Reasons to Consider DHE for Migraine Treatment - Virtual Headache Specialist](https://virtualheadachespecialist.com/wp-content/uploads/2022/01/VHS-Trudhesa-30-mins.jpg)
Trudhesa DHE Nasal Spray: Top 7 Reasons to Consider DHE for Migraine Treatment - Virtual Headache Specialist
![DHE and POD® (Precision Olfactory Delivery) Technology | Trudhesa® (dihydroergotamine mesylate) nasal spray | Official Website DHE and POD® (Precision Olfactory Delivery) Technology | Trudhesa® (dihydroergotamine mesylate) nasal spray | Official Website](https://www.trudhesa.com/wp-content/uploads/Trudhesa-POD-vertical-tilt-left-bnw.png)
DHE and POD® (Precision Olfactory Delivery) Technology | Trudhesa® (dihydroergotamine mesylate) nasal spray | Official Website
![Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine | Mobile Health Times Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine | Mobile Health Times](http://www.mobilehealthtimes.com/wp-content/uploads/2021/09/Impel-NeuroPharma-777x437.jpg)
Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine | Mobile Health Times
![Dihydroergotamine Mesylate Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx Only Dihydroergotamine Mesylate Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx Only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=dihydroergotamine-mesylate-nasal-spray-6.jpg&id=661708)
Dihydroergotamine Mesylate Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx Only
![Advancing Migraine Treatment: Exploring the Applications of DHE in the Upper Nasal Space - Association of Migraine Disorders Advancing Migraine Treatment: Exploring the Applications of DHE in the Upper Nasal Space - Association of Migraine Disorders](https://www.migrainedisorders.org/wp-content/uploads/2023/07/Advancing-Migraine-Treatment-Exploring-the-Applications-of-DHE-in-the-Upper-Nasal-Space-1-scaled.jpg)
Advancing Migraine Treatment: Exploring the Applications of DHE in the Upper Nasal Space - Association of Migraine Disorders
![Dihydroergotamine Mesylate Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx Only Dihydroergotamine Mesylate Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx Only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=dihydroergotamine-mesylate-nasal-spray-5.jpg&id=661708)